Cargando…

The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden

BACKGROUND: To explore the determinants of incident hypertension, and especially the impact of baseline blood pressure categories, in a representative Swedish population. METHODS: A 10-year longitudinal study of residents aged 30–74. Blood pressures were measured and categorized according to ESH gui...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindblad, Ulf, Lundholm, Klara, Eckner, Jenny, Li, Ying, Råstam, Lennart, Hellgren, I. Margareta, Daka, Bledar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556935/
https://www.ncbi.nlm.nih.gov/pubmed/34715783
http://dx.doi.org/10.1186/s12872-021-02334-6
_version_ 1784592272951607296
author Lindblad, Ulf
Lundholm, Klara
Eckner, Jenny
Li, Ying
Råstam, Lennart
Hellgren, I. Margareta
Daka, Bledar
author_facet Lindblad, Ulf
Lundholm, Klara
Eckner, Jenny
Li, Ying
Råstam, Lennart
Hellgren, I. Margareta
Daka, Bledar
author_sort Lindblad, Ulf
collection PubMed
description BACKGROUND: To explore the determinants of incident hypertension, and especially the impact of baseline blood pressure categories, in a representative Swedish population. METHODS: A 10-year longitudinal study of residents aged 30–74. Blood pressures were measured and categorized according to ESH guidelines with optimal blood pressure < 120/80 mmHg, normal 120–129/80–84 mmHg, and high normal 130–139/85–89 mmHg. Incident hypertension was defined as ongoing treatment or three consecutive blood pressure readings ≥ 140/ ≥ 90 mmHg (one or both) at follow-up, while those with ≥ 140 and/or ≥ 90 mmHg at only one or two visits were labelled as unstable. After excluding subjects with hypertension, ongoing blood pressure lowering medication or a previous CVD event at baseline, 1099 remained for further analyses. RESULTS: Sixteen (2.6%) subjects with optimal baseline blood pressure had hypertension at follow up. Corresponding numbers for subjects with normal, high normal and unstable blood pressure were 55 (19.4%), 50 (39.1%) and 46 (74.2%), respectively. Compared with subjects in optimal group those in normal, high normal and unstable blood pressure categories had significantly higher risk to develop manifest hypertension with odds ratios OR and (95% CI) of 7.04 (3.89–12.7), 17.1 (8.88–33.0) and 84.2 (37.4–190), respectively, with adjustment for age, BMI and family history for hypertension. The progression to hypertension was also independently predicted by BMI (p < 0.001), however, not by age. CONCLUSIONS: Subjects with high normal or unstable blood pressure should be identified in clinical practice, evaluated for global hypertension risk and offered personalized advice on lifestyle modification for early prevention of manifest hypertension and cardiovascular disease.
format Online
Article
Text
id pubmed-8556935
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85569352021-11-01 The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden Lindblad, Ulf Lundholm, Klara Eckner, Jenny Li, Ying Råstam, Lennart Hellgren, I. Margareta Daka, Bledar BMC Cardiovasc Disord Research Article BACKGROUND: To explore the determinants of incident hypertension, and especially the impact of baseline blood pressure categories, in a representative Swedish population. METHODS: A 10-year longitudinal study of residents aged 30–74. Blood pressures were measured and categorized according to ESH guidelines with optimal blood pressure < 120/80 mmHg, normal 120–129/80–84 mmHg, and high normal 130–139/85–89 mmHg. Incident hypertension was defined as ongoing treatment or three consecutive blood pressure readings ≥ 140/ ≥ 90 mmHg (one or both) at follow-up, while those with ≥ 140 and/or ≥ 90 mmHg at only one or two visits were labelled as unstable. After excluding subjects with hypertension, ongoing blood pressure lowering medication or a previous CVD event at baseline, 1099 remained for further analyses. RESULTS: Sixteen (2.6%) subjects with optimal baseline blood pressure had hypertension at follow up. Corresponding numbers for subjects with normal, high normal and unstable blood pressure were 55 (19.4%), 50 (39.1%) and 46 (74.2%), respectively. Compared with subjects in optimal group those in normal, high normal and unstable blood pressure categories had significantly higher risk to develop manifest hypertension with odds ratios OR and (95% CI) of 7.04 (3.89–12.7), 17.1 (8.88–33.0) and 84.2 (37.4–190), respectively, with adjustment for age, BMI and family history for hypertension. The progression to hypertension was also independently predicted by BMI (p < 0.001), however, not by age. CONCLUSIONS: Subjects with high normal or unstable blood pressure should be identified in clinical practice, evaluated for global hypertension risk and offered personalized advice on lifestyle modification for early prevention of manifest hypertension and cardiovascular disease. BioMed Central 2021-10-29 /pmc/articles/PMC8556935/ /pubmed/34715783 http://dx.doi.org/10.1186/s12872-021-02334-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lindblad, Ulf
Lundholm, Klara
Eckner, Jenny
Li, Ying
Råstam, Lennart
Hellgren, I. Margareta
Daka, Bledar
The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden
title The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden
title_full The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden
title_fullStr The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden
title_full_unstemmed The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden
title_short The 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern Sweden
title_sort 10-year incidence of hypertension across blood pressure categories in a population-based cohort in southwestern sweden
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556935/
https://www.ncbi.nlm.nih.gov/pubmed/34715783
http://dx.doi.org/10.1186/s12872-021-02334-6
work_keys_str_mv AT lindbladulf the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT lundholmklara the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT ecknerjenny the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT liying the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT rastamlennart the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT hellgrenimargareta the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT dakabledar the10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT lindbladulf 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT lundholmklara 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT ecknerjenny 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT liying 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT rastamlennart 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT hellgrenimargareta 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden
AT dakabledar 10yearincidenceofhypertensionacrossbloodpressurecategoriesinapopulationbasedcohortinsouthwesternsweden